Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
Elena Abati, Arianna Manini, Giacomo P. Comi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Oxidative stress: Roles in skeletal muscle atrophy
Han Zhang, Guangdong Qi, Kexin Wang, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115664-115664
Closed Access | Times Cited: 101
Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies
Dequan Liu, Shijin Wang, Shuang Liu, et al.
Molecular Aspects of Medicine (2024) Vol. 97, pp. 101270-101270
Open Access | Times Cited: 20
The Potential of Superoxide Dismutase-Rich Tetraselmis chuii as a Promoter of Cellular Health
Stuart P. Cocksedge, Lalia Mantecón, Enrique Castaño, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1693-1693
Open Access | Times Cited: 2
Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies
Kexin Wang, Liu Qing-yuan, Mingyu Tang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115407-115407
Open Access | Times Cited: 52
Licochalcone A and B enhance muscle proliferation and differentiation by regulating Myostatin
Khurshid Ahmad, Eun Ju Lee, Shahid Ali, et al.
Phytomedicine (2024) Vol. 125, pp. 155350-155350
Open Access | Times Cited: 9
Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches
Yalda Rahbar Saadat, Amin Abbasi, Seyyed Sina Hejazian, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Therapeutic targeting ofALSpathways: Refocusing an incomplete picture
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
Combination disease‐modifying treatment in spinal muscular atrophy: A proposed classification
Crystal M. Proud, Eugenio Mercuri, Richard S. Finkel, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 2155-2160
Open Access | Times Cited: 15
The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases
Xuepeng Bian, Qian Wang, Yibing Wang, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 6
Spinal Muscular Atrophy Scoliosis in the Era of Background Therapies—A Review of the Literature
Fred Ruythooren, Pierre Moens
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3467-3467
Open Access | Times Cited: 5
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study
Thomas O. Crawford, John Day, Darryl C. De Vivo, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients
Laurane Mackels, Virginie Mariot, L. Buscemi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8763-8763
Open Access | Times Cited: 5
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases
Muhammad Usman Munir, Syed Aoun Ali, Ka Hang Karen Chung, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Bioanalytical methods in doping controls: a review
Andreas Thomas, Katja Walpurgis, Nana Naumann, et al.
Bioanalysis (2025), pp. 1-12
Closed Access
Effect of transcutaneous electrical acupoint stimulation on postoperative muscle atrophy in patients with foot and ankle fracture: A randomized controlled pilot study
Ying Xue, Xiaoqian Dai, Xueming Chen, et al.
Journal of Traditional Chinese Medical Sciences (2025)
Open Access
Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy
Ana Letícia Amorim de Albuquerque, Júlia Kersting Chadanowicz, Giovanna Câmara Giudicelli, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 3
Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy
Laurent Servais, Lindsey Lair, Anne M. Connolly, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10273-10273
Open Access | Times Cited: 3
Beta2‐Adrenergic Stimulation Induces Resistance Training‐Like Adaptations in Human Skeletal Muscle: Potential Role of KLHL41
Søren Jessen, Júlia Prats Quesada, Andrea Di Credico, et al.
Scandinavian Journal of Medicine and Science in Sports (2024) Vol. 34, Iss. 10
Open Access | Times Cited: 3
Glycine soja extract alleviates muscle atrophy and inflammatory factors in sciatic nerve injury rats and prevents protein degradation in C2C12 myoblasts
Young Sook Kim, Eunjung Son, Seung‐Hyung Kim, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106723-106723
Closed Access
Glycyrrhiza uralensis crude water extract and licochalcone A and B to enhance chicken muscle satellite cell differentiation for cultured meat production
Eun Ju Lee, Sibhghatulla Shaikh, Jin Hee Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Giorgia Querin, M. Gómez García de la Banda, Piera Smeriglio
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management
Mazen Elsheikh, Ahmed El Sabagh, Islam Mohamed, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 46, pp. 6028-6048
Open Access | Times Cited: 6
Role of Myostatin in Rheumatoid Arthritis: A Review of the Clinical Impact
Fabiola González-Ponce, Melissa Ramírez-Villafaña, Eli Efraín Gómez-Ramírez, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1085-1085
Open Access | Times Cited: 2
The Role of Branched Chain Ketoacid Dehydrogenase Kinase (BCKDK) in Skeletal Muscle Biology and Pathogenesis
Joshua Fernicola, Sagar Vyavahare, Sonu Kumar Gupta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7601-7601
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top